ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
41.00
0.00%
US Tech 100
21,549.20
-0.12%
S&P 500
6,129.58
0.24%
US Dollar vs CAD
1.42049
0.10%
Bitcoin
96,259.55
0.73%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Medicenna Therapeutics Corporation (MDNA) Share Price

Medicenna Therapeutics Corporation

Medicenna Therapeutics Corporation (MDNA)

Medicenna Therapeutics Corp
0.157
0.00
(0.00%)
Closed February 18 3:00PM
Delayed by 15 minutes
0.157
0.00
( 0.00% )
Pre Market: 6:00PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.157
Bid
0.1565
Ask
0.1612
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
10.933M
Previous Close
0.157
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
69,637,000
Dividend Yield
-
PE Ratio
-3.47
Earnings Per Share (EPS)
-0.37
Revenue
-
Net Profit
-25.47M

About Medicenna Therapeutics Corporation

Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically ... Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The have the potential to purge the tumor and un-blind the immune system to cancer thereby altering the treatment paradigm for a large majority of cancer patients. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.medicenna.com
Headquarters
Toronto, Ontario, Can
Founded
-

Ask ADVFN Intelligence (AI)

MDNA Latest News

More News

Form 15-12G - Securities registration termination [Section 12(g)]
Edgar (US Regulatory)
May 14 2024
MDNA (0.00%)

Form D - Notice of Exempt Offering of Securities
Edgar (US Regulatory)
May 14 2024
MDNA (0.00%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
May 13 2024
MDNA (0.00%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
April 30 2024
MDNA (0.00%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
April 26 2024
MDNA (0.00%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
April 25 2024
MDNA (0.00%)

Form AW - Amendment Withdrawal Request
Edgar (US Regulatory)
April 22 2024
MDNA (0.00%)

Form F-3/A - Registration statement by foreign private issuers: [Amend]
Edgar (US Regulatory)
April 16 2024
MDNA (0.00%)

Form F-10POS - Post-effective amendment to a F-10EF registration
Edgar (US Regulatory)
April 16 2024
MDNA (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

MDNA - Frequently Asked Questions (FAQ)

What is the current Medicenna Therapeutics share price?
The current share price of Medicenna Therapeutics is US$ 0.157
How many Medicenna Therapeutics shares are in issue?
Medicenna Therapeutics has 69,637,000 shares in issue
What is the market cap of Medicenna Therapeutics?
The market capitalisation of Medicenna Therapeutics is USD 10.93M
What is the 1 year trading range for Medicenna Therapeutics share price?
Medicenna Therapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Medicenna Therapeutics?
The price to earnings ratio of Medicenna Therapeutics is -3.47
What is the reporting currency for Medicenna Therapeutics?
Medicenna Therapeutics reports financial results in CAD
What is the latest annual profit for Medicenna Therapeutics?
The latest annual profit of Medicenna Therapeutics is CAD -25.47M
What is the registered address of Medicenna Therapeutics?
The registered address for Medicenna Therapeutics is 200 - 1920 YONGE STREET, TORONTO, ONTARIO, M4S 3E2
What is the Medicenna Therapeutics website address?
The website address for Medicenna Therapeutics is www.medicenna.com
Which industry sector does Medicenna Therapeutics operate in?
Medicenna Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MDBHMDB Capital Holdings LLC
US$ 11.14
(61.33%)
8
SINTSiNtx Technologies Inc
US$ 4.54
(60.99%)
2.58M
BSBKBogota Financial Corporation
US$ 12.41
(59.92%)
8
TCBSTexas Community Bancshares Inc
US$ 25.44
(57.52%)
6
INTGIntergroup Corporation
US$ 21.94
(53.64%)
7
TLFTandy Leather Factory Inc
US$ 2.20
(-59.41%)
7
NSINational Security Emerging Markets Index ETF
US$ 11.01
(-59.03%)
8
MTVAMetaVia Inc
US$ 0.6765
(-59.00%)
302
NVDWTradr 1.75X Long NVDW Weekly ETF
US$ 13.01
(-55.14%)
6
TACTTransAct Technologies Inc
US$ 2.01
(-54.42%)
1
ADTXAditxt Inc
US$ 0.1329
(20.82%)
59.56M
LYTLytus Technologies Holdings PTV Ltd
US$ 0.3354
(50.67%)
31.1M
TRUGTruGolf Holdings Inc
US$ 0.54
(32.03%)
9.69M
DGLYDigital Ally Inc
US$ 0.1129
(7.73%)
7.41M
RSLSReShape Lifesciences Inc
US$ 1.51
(39.81%)
6.8M

Discussion

View Full Feed
tw0122 tw0122 1 minute ago
OSRH $5.66 + 81% new listing very high risk  style="font-size: 1em; caret-color: rgb(55, 55, 55); color: rgba(55, 55, 55, 1); font-family: proxima-nova, sans-serif; background-color: rgba(255, 255, 255, 1)"OSR Holdings will begin trading on the Nasdaq Stock Market LLC on  style="font-size: 1e
SkeBallLarry SkeBallLarry 2 minutes ago
Trump's FBI pick Kash Patel advances in full >

Senate procedural vote before expected confirmation >
https://nypost.com/2025/02/18/us-news/trumps-fbi-pick-kash-patel-advances-in-full-senate-procedural-vote-before-expected-confirmation/
SkeBallLarry SkeBallLarry 2 minutes ago
Trump's FBI pick Kash Patel advances in full >

Senate procedural vote before expected confirmation >
https://nypost.com/2025/02/18/us-news/trumps-fbi-pick-kash-patel-advances-in-full-senate-procedural-vote-before-expected-confirmation/
SkeBallLarry SkeBallLarry 2 minutes ago
Trump's FBI pick Kash Patel advances in full >

Senate procedural vote before expected confirmation >
https://nypost.com/2025/02/18/us-news/trumps-fbi-pick-kash-patel-advances-in-full-senate-procedural-vote-before-expected-confirmation/
Krombacher Krombacher 3 minutes ago
Response to Noradio:

I see where you're coming from, and your logic makes sense if naked shorting were completely risk-free. But it’s not. Here’s why they still feel the need to run a propaganda campaign:

1️⃣ Naked Shorting is Not Risk-Free—They Still Need to Manage Per
DBMM
SkeBallLarry SkeBallLarry 3 minutes ago
Trump's FBI pick Kash Patel advances in full >

Senate procedural vote before expected confirmation >
https://nypost.com/2025/02/18/us-news/trumps-fbi-pick-kash-patel-advances-in-full-senate-procedural-vote-before-expected-confirmation/
ChannelTrader ChannelTrader 3 minutes ago
Trump Goes Scorched Earth, Fires All ‘Biden Era’ US Attorneys

https://truthpress.com/news/trump-goes-scorched-earth-fires-all-biden-era-us-attorneys/?utm_source=truthpress.beehiiv.com&utm_medium=newsletter&utm_campaign=judge-rules-on-doge&_bhlid=d1141d64e51f50bbbf8989602f0c3283fc74c92
Copilotdog Copilotdog 4 minutes ago
I spoke to Jeff in November. He said he would update the investors in January. It's almost March. He's done.
PSYCF
MirageRiver2 MirageRiver2 5 minutes ago
Yes yes we are familiar with your evidence. Basically if you don’t understand it, its a lie, fraud or failure
ELTP
JustJack JustJack 5 minutes ago
GLTY. Why not tell us what you saw in the company, what brought you here, why you like it and what worries you about what you read in your extensive evaluation before you pulled the trigger.
AITX
capgain capgain 6 minutes ago
Nice!
ChannelTrader ChannelTrader 6 minutes ago
Judge Rules on Dem-Led Effort to Block DOGE from Accessing Government Data

https://truthpress.com/news/judge-rules-on-dem-led-effort-to-block-doge-from-accessing-government-data/?utm_source=truthpress.beehiiv.com&utm_medium=newsletter&utm_campaign=judge-rules-on-doge&_bhlid=fe2f483f7b
MirageRiver2 MirageRiver2 7 minutes ago
Is it a good idea to advertise stock manipulation?
ELTP
tw0122 tw0122 8 minutes ago
SINT $3.90 + 38%
SINT
SkeBallLarry SkeBallLarry 10 minutes ago
US judge temporarily halts firings of 11 CIA officers, lawyer says

https://www.msn.com/en-us/news/us/us-judge-temporarily-halts-firings-of-11-cia-officers-lawyer-says/ar-AA1zjlXa?ocid=msedgntp&pc=HCTS&cvid=070e6b2d4d7c4b69ca01c49fb4a0db90&ei=41
VVVVVV VVVVVV 12 minutes ago
Nice try to scare shareholders lol

If anything, it would appear to be good news. Who really knows. It shouldn’t have been scheduled prior to the reconsideration decision anyway.

IMHO
VPLM
SkeBallLarry SkeBallLarry 12 minutes ago
Trump orders DOJ to terminate all remaining >

‘Biden Era’ US attorneys: ‘We must clean house’ >
https://nypost.com/2025/02/18/us-news/trump-orders-doj-to-terminate-all-remaining-biden-era-us-attorneys/
ChannelTrader ChannelTrader 12 minutes ago
Good, I like Gen, Flynn, he's a good man.
SkeBallLarry SkeBallLarry 13 minutes ago
Trump orders DOJ to terminate all remaining >

‘Biden Era’ US attorneys: ‘We must clean house’ >
https://nypost.com/2025/02/18/us-news/trump-orders-doj-to-terminate-all-remaining-biden-era-us-attorneys/
TMaga TMaga 14 minutes ago
Buys: 6,368,799
Neutral: 0
Sells: 74,137,977
HCMC
KOmani KOmani 16 minutes ago
In the IPO documents, you can see they converted debt at a price of $0.46/share.

Pretty misleading to outsiders to have an IPO at $6.00
XHLD
TRAPPER JIM TRAPPER JIM 17 minutes ago
I never sleep for very long. But it sure seems like the older I get the less I sleep 
The ELTP King The ELTP King 17 minutes ago
Here's what everyone doesn't realize (except for me):

When Nasrat made the comment of "cut that prediction in half or more than half", he ALSO stated that Generic OxyContin was going to be approved in 2024, that Generic Concerta was going to be submitted in 2024, and that QUOTE "at le
ELTP
Cryptohemingway Cryptohemingway 19 minutes ago
WOW, 8-K fillings, a change is coming
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001710495/000149315225007235/form8-k.htm
PNXP

Your Recent History

NASDAQ
MDNA
Medicenna Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads